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| INTRODUC TI ON
LP showed stable parameters. The patient was followed-up until his demise 2 months later due to progression of heart failure.
| D ISCUSS I ON
We present a patient with limited venous access who meets both pacing and defibrillation indications and offer our experience on the simultaneous use of S-ICD and LP. There were no interactions detected between the LP and the S-ICD. In addition, the LP continued to function normally after two high output shocks from the S-ICD proving the integrity of both systems. A complex venoplasty to relieve the right subclavian occlusion was deemed to be high risk. We avoided an epicardial system which would require a thoracotomy for a patient at a high cardiovascular risk for general anesthesia. As our patient had an overall low pacing burden, we accepted the risk of losing AV synchrony. A limitation of the S-ICD is that it is unable to detect and treat tachyarrhythmias below 170 beats per minute, and is unable to perform antitachycardia pacing. The preliminary result of a modular pacing system (Empower; Boston Scientific Corp) leveraging on wireless communication between a LP and S-ICD allowing ATP for VA is promising and we eagerly await future trials on this system.
Even though the patient passed S-ICD screening, it is possible that QRS (refers to the QRS complex of the cardiac electrogram) double counting or T wave oversensing could have occurred during paced rhythm. One way to overcome this would be to perform pacing with a diagnostic catheter prior to S-ICD implant, or to implant the LP prior to implanting the S-ICD. However, due to the requirement for heparin administration during LP implant, the decision was made to implant the S-ICD first, and ensure adequate hemostasis prior to LP implant. Also, diagnostic pacing was not performed to minimize procedure time and risk of infection.
To our knowledge, this is the first case of a simultaneous LP and S-ICD implantation in the same setting demonstrating preserved integrity in both systems post defibrillation testing and shock for spontaneous VA. This is a viable alternative for patients with vascular access issues requiring pacing for bradycardia as well as defibrillation for VA. Simultaneous implant was preferred over separate implant procedures to avoid the patient having to return for a separate procedure, as well as to minimize infection risk.
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